This inventor holds 1 USPTO granted patent. Top assignees: Dana-Farber-Cancer Institute Inc., Washington University. Active years: 2011.
Company Filing History:
1 out of 1,266 
1 out of 1,379 
Years Active: 2011
Title: Joshua Rubin - Innovator in Chemokine Receptor Antibodies
Introduction
Joshua Rubin is a notable inventor based in Webster Groves, MO (US). He has made significant contributions to the field of biochemistry, particularly in the development of chemokine receptor antibodies. His innovative work has implications for various diagnostic and therapeutic applications.
Latest Patents
Rubin holds a patent for "Phosphospecific chemokine receptor antibodies." This invention provides chemokine receptor antibodies that selectively bind to an activated form of the receptor but not to a non-activated form. The antibodies developed can be utilized in several diagnostic, screening, and purification methods, showcasing their potential in medical research and treatment.
Career Highlights
Throughout his career, Joshua Rubin has worked with prestigious institutions, including Washington University and Dana-Farber Cancer Institute Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
One of his notable collaborators is Andrew L Kung. Their partnership has likely fostered advancements in their shared research interests, particularly in the realm of cancer and immunology.
Conclusion
Joshua Rubin's contributions to the field of chemokine receptor antibodies highlight his innovative spirit and dedication to advancing medical science. His work continues to influence diagnostic and therapeutic strategies in healthcare.